Removal of potential phosphorylation sites does not alter creatine transporter response to PKC or substrate availability

Lucia Santacruz, Marcus D. Darrabie, Rajashree Mishra, Danny Jacobs

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Creatine, Phosphocreatine, and creatine kinases, constitute an energy shuttle that links ATP production in mitochondria with cellular consumption sites. Myocytes and neurons cannot synthesize creatine and depend on uptake across the cell membrane by a specialized transporter to maintain intracellular creatine levels. Although recent studies have improved our understanding of creatine transport in cardiomyocytes, the structural elements underlying the creatine transporter protein regulation and the relevant intracellular signaling processes are unknown. Methods: The effects of pharmacological activation of kinases or phosphatases on creatine transport in cardiomyocytes in culture were evaluated. Putative phosphorylation sites in the creatine transporter protein were identified by bioinformatics analyses, and ablated using site-directed mutagenesis. Mutant transporter function and their responses to pharmacological PKC activation or changes in creatine availability in the extracellular environment, were evaluated. Results: PKC activation decreases creatine transport in cardiomyocytes in culture. Elimination of high probability potential phosphorylation sites did not abrogate responses to PKC activation or substrate availability. Conclusion: Modulation of creatine transport in cardiomyocytes is a complex process where phosphorylation at predicted sites in the creatine transporter protein does not significantly alter activity. Instead, nonclassical structural elements in the creatine transporter and/or interactions with regulatory subunits may modulate its activity.

Original languageEnglish (US)
Pages (from-to)353-360
Number of pages8
JournalCellular Physiology and Biochemistry
Volume37
Issue number1
DOIs
StatePublished - Aug 12 2015
Externally publishedYes

Fingerprint

Creatine
Phosphorylation
Cardiac Myocytes
Pharmacology
Proteins
Phosphocreatine
creatine transporter
Creatine Kinase
Site-Directed Mutagenesis
Computational Biology
Phosphoric Monoester Hydrolases
Muscle Cells
Mitochondria
Phosphotransferases
Adenosine Triphosphate
Cell Membrane
Neurons

Keywords

  • Cardiac metabolism
  • Creatine
  • Energy metabolism
  • Membrane transport
  • Phosphorylation
  • Protein kinase C (PKC)

ASJC Scopus subject areas

  • Physiology

Cite this

Removal of potential phosphorylation sites does not alter creatine transporter response to PKC or substrate availability. / Santacruz, Lucia; Darrabie, Marcus D.; Mishra, Rajashree; Jacobs, Danny.

In: Cellular Physiology and Biochemistry, Vol. 37, No. 1, 12.08.2015, p. 353-360.

Research output: Contribution to journalArticle

@article{9368acb6f9114830a46e85fb55d90e68,
title = "Removal of potential phosphorylation sites does not alter creatine transporter response to PKC or substrate availability",
abstract = "Background: Creatine, Phosphocreatine, and creatine kinases, constitute an energy shuttle that links ATP production in mitochondria with cellular consumption sites. Myocytes and neurons cannot synthesize creatine and depend on uptake across the cell membrane by a specialized transporter to maintain intracellular creatine levels. Although recent studies have improved our understanding of creatine transport in cardiomyocytes, the structural elements underlying the creatine transporter protein regulation and the relevant intracellular signaling processes are unknown. Methods: The effects of pharmacological activation of kinases or phosphatases on creatine transport in cardiomyocytes in culture were evaluated. Putative phosphorylation sites in the creatine transporter protein were identified by bioinformatics analyses, and ablated using site-directed mutagenesis. Mutant transporter function and their responses to pharmacological PKC activation or changes in creatine availability in the extracellular environment, were evaluated. Results: PKC activation decreases creatine transport in cardiomyocytes in culture. Elimination of high probability potential phosphorylation sites did not abrogate responses to PKC activation or substrate availability. Conclusion: Modulation of creatine transport in cardiomyocytes is a complex process where phosphorylation at predicted sites in the creatine transporter protein does not significantly alter activity. Instead, nonclassical structural elements in the creatine transporter and/or interactions with regulatory subunits may modulate its activity.",
keywords = "Cardiac metabolism, Creatine, Energy metabolism, Membrane transport, Phosphorylation, Protein kinase C (PKC)",
author = "Lucia Santacruz and Darrabie, {Marcus D.} and Rajashree Mishra and Danny Jacobs",
year = "2015",
month = "8",
day = "12",
doi = "10.1159/000430359",
language = "English (US)",
volume = "37",
pages = "353--360",
journal = "Cellular Physiology and Biochemistry",
issn = "1015-8987",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Removal of potential phosphorylation sites does not alter creatine transporter response to PKC or substrate availability

AU - Santacruz, Lucia

AU - Darrabie, Marcus D.

AU - Mishra, Rajashree

AU - Jacobs, Danny

PY - 2015/8/12

Y1 - 2015/8/12

N2 - Background: Creatine, Phosphocreatine, and creatine kinases, constitute an energy shuttle that links ATP production in mitochondria with cellular consumption sites. Myocytes and neurons cannot synthesize creatine and depend on uptake across the cell membrane by a specialized transporter to maintain intracellular creatine levels. Although recent studies have improved our understanding of creatine transport in cardiomyocytes, the structural elements underlying the creatine transporter protein regulation and the relevant intracellular signaling processes are unknown. Methods: The effects of pharmacological activation of kinases or phosphatases on creatine transport in cardiomyocytes in culture were evaluated. Putative phosphorylation sites in the creatine transporter protein were identified by bioinformatics analyses, and ablated using site-directed mutagenesis. Mutant transporter function and their responses to pharmacological PKC activation or changes in creatine availability in the extracellular environment, were evaluated. Results: PKC activation decreases creatine transport in cardiomyocytes in culture. Elimination of high probability potential phosphorylation sites did not abrogate responses to PKC activation or substrate availability. Conclusion: Modulation of creatine transport in cardiomyocytes is a complex process where phosphorylation at predicted sites in the creatine transporter protein does not significantly alter activity. Instead, nonclassical structural elements in the creatine transporter and/or interactions with regulatory subunits may modulate its activity.

AB - Background: Creatine, Phosphocreatine, and creatine kinases, constitute an energy shuttle that links ATP production in mitochondria with cellular consumption sites. Myocytes and neurons cannot synthesize creatine and depend on uptake across the cell membrane by a specialized transporter to maintain intracellular creatine levels. Although recent studies have improved our understanding of creatine transport in cardiomyocytes, the structural elements underlying the creatine transporter protein regulation and the relevant intracellular signaling processes are unknown. Methods: The effects of pharmacological activation of kinases or phosphatases on creatine transport in cardiomyocytes in culture were evaluated. Putative phosphorylation sites in the creatine transporter protein were identified by bioinformatics analyses, and ablated using site-directed mutagenesis. Mutant transporter function and their responses to pharmacological PKC activation or changes in creatine availability in the extracellular environment, were evaluated. Results: PKC activation decreases creatine transport in cardiomyocytes in culture. Elimination of high probability potential phosphorylation sites did not abrogate responses to PKC activation or substrate availability. Conclusion: Modulation of creatine transport in cardiomyocytes is a complex process where phosphorylation at predicted sites in the creatine transporter protein does not significantly alter activity. Instead, nonclassical structural elements in the creatine transporter and/or interactions with regulatory subunits may modulate its activity.

KW - Cardiac metabolism

KW - Creatine

KW - Energy metabolism

KW - Membrane transport

KW - Phosphorylation

KW - Protein kinase C (PKC)

UR - http://www.scopus.com/inward/record.url?scp=84941123610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941123610&partnerID=8YFLogxK

U2 - 10.1159/000430359

DO - 10.1159/000430359

M3 - Article

C2 - 26316082

AN - SCOPUS:84941123610

VL - 37

SP - 353

EP - 360

JO - Cellular Physiology and Biochemistry

JF - Cellular Physiology and Biochemistry

SN - 1015-8987

IS - 1

ER -